• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SNW2:GR

40.016 EUR 0.795 2.03%

As of 03:05:25 ET on 08/22/2014.

Snapshot for Sanofi (SNW2)

Open: 40.190 Day's Range: 40.016 - 40.295 Volume: 0
Previous Close: 39.221 52wk Range: 34.433 - 40.383 1-Yr Rtn: +12.40%

Stock Chart for SNW2

No chart data available.
  • SNW2:GR 40.016
  • 1D
  • 1M
  • 1Y
39.221
Interactive SNW2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNW2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.3494
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.6070
Est. PEG Ratio 1.9596
Market Cap (M EUR) 105,707.03
Shares Outstanding (M) 2,641.62
30 Day Average Volume 53
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.43%
Cash Dividend (USD) 1.5983
Dividend Ex-Date 05/07/2014
5 Year Dividend Growth 3.30%
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNW2

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SNW2

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergChairmanChristopher A Viehbacher "Chris"Chief Executive Officer
Anne C BealChief Patient OfficerElias A ZerhouniPres:Global Research & Dev
More Company Profile & Key Executives for SNW2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil